Laryngeal angiosarcoma is a rare disease with poor prognosis where 47% of patients die of disseminated disease, though serial resection may be beneficial in some cases.
Answers are grounded in this paper and cite their sources.
Alerts clinicians to high disseminated mortality risk in laryngeal angiosarcoma; extends sparse evidence and supports systemic therapy trials.
BACKGROUND: Laryngeal angiosarcoma is rare and the prognosis is poor. The purpose of this study was to describe the first case of cutaneous angiosarcoma metastatic to the larynx and systematically review all cases of laryngeal angiosarcoma. METHODS: A 61-year-old man presented with an alar lesion diagnosed as angiosarcoma and was treated with wide local resection and radiation. Six years later, he presented with a laryngeal mass histologically similar to the initial tumor. A systematic review of reported cases of angiosarcoma of the larynx was performed. RESULTS: Eighteen cases were identified. Mean age of presentation was 64.3 years. Men represented 66.7%. Mean follow-up was 34.1 months. Forty-seven percent died with disseminated disease at a mean of 18.4 months. Our patient did well with serial resection. CONCLUSION: To the best of our knowledge, this case represents the first documented case of cutaneous angiosarcoma metastatic to the larynx and suggests that serial resection with long-term surveillance may be of benefit in some cases.
No takes yet. Share an insight, caveat, or question.
Qualls et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: